2.77
+0.27(+10.80%)
Currency In USD
| Previous Close | 2.5 |
| Open | 2.52 |
| Day High | 2.86 |
| Day Low | 2.52 |
| 52-Week High | 5.24 |
| 52-Week Low | 2.28 |
| Volume | 11,935 |
| Average Volume | 41,926 |
| Market Cap | 113.2M |
| PE | -1.49 |
| EPS | -1.86 |
| Moving Average 50 Days | 2.95 |
| Moving Average 200 Days | 3.62 |
| Change | 0.27 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $191.03 as of April 03, 2025 at a share price of $2.77. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $439.68 as of April 03, 2025 at a share price of $2.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes
GlobeNewswire Inc.
7 hours ago
Introduction of EluPro at Heart Rhythm 2025 in San Diego, April 25-27, 2025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, is proud to ann
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
GlobeNewswire Inc.
Mar 27, 2025 8:05 PM GMT
Seventh GPO Agreement Signed Since EluPro’s Launch SILVER SPRING, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced that it has entered into an ag
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
GlobeNewswire Inc.
Mar 25, 2025 8:05 PM GMT
— Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) infections — SILVER SPRING, Md., March 25, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elut